Shanghai Shen Lian Biomedical Corporation

¥7.21As of Sun 8 Nov 2026, 12:00 UTC
SSE:688098Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (13.54%)
Div yield —
ROE (2.46%)
Biotechnology
Beta (5Y) 0.62
PE TTM —
TSR TTM (35.62%)
Mkt cap ¥2.961B
ROIC (1.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.60
19.25%
(60.49%)
Hold 11|5|12|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.08
0.08
0.08
8.89%
10.77%
10.11%
11.30%
Revenue¥M
314.1
310.4
328.2
323.2
8.98%
4.50%
5.63%
2.68%
Peers (US$443.8M)
Cap (US$)
PE
440.2M
212.0x
447.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.620
(0.193)
(0.194)
EBIT/Intx
0.775
0.071
0.093
Own earn%
(178.25)
(177.62)
(124.92)
Sh yield%
38.68
14.57
18.96
Owners
Insiders/Inst%
13.96
26.36
Short interest%
5.95
SBC / revenue%
0.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
8–18
$1 testx
0.0
Incr. ROIC%
3